Products for Research Use Only
RegisterLogin

RET-IN-8

CAT: 0804-HY-143545Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-143545Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
RET-IN-8 is a rearranged during transfection (RET) kinase inhibitor extracted from patent WO2021093720A1 compound I-1. RET-IN-8 can be used for the research of cancer[1].
CAS Number
2642164-75-6
UNSPSC
12352005
Target
RET
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ret-in-8.html
Solubility
10 mM in DMSO
Smiles
N#CC1=C2C(C3=CC=C(N4CCN(C([C@H](O)C(C)C)=O)CC4)N=C3)=CC(C5=CCOCC5)=CN2N=C1
Molecular Formula
C27H30N6O3
Molecular Weight
486.57
References & Citations
[1]Gou J, et, al. Pyrazole[1,5-a]pyridine-3-nitrile compound and pharmaceutical use thereof. WO2021093720A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-112950RET-IN-1
HY-133553-01RET-IN-3
HY-145024RET-IN-6
HY-145023RET-IN-5
HY-178786RET-IN-31
HY-144422RET-IN-15
HY-148742-01RET-IN-21
HY-153676-01RET-IN-23
HY-147563RET-IN-17
HY-141896-01RET-IN-7

Alternative Products

CatalogName
MBS5805905RET-IN-8
R1701-17RET protein (RET)
V8277-100UGRET Antibody / c-RET
V8276-100UGC-RET Antibody / RET
030598RET (ret proto-oncogene)
332425-01Ret

Popular Products